Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Patients with COPD may be missing out on appropriate treatment because of incorrect or no diagnosis

07.09.2004


Patients with Chronic Obstructive Pulmonary Disease (COPD) are frequently misdiagnosed or remain undiagnosed, and may therefore be missing out on appropriate treatment, according to the results of a primary care study presented today at the annual European Respiratory Society (ERS) meeting in Glasgow, Scotland.1

COPD is a progressive respiratory disease that causes significant deterioration of lung function and chronic breathlessness that can lead to severe disability.2 Limited airflow associated with COPD leads to excess air being trapped in the lungs after a person has exhaled. This condition, known as "air trapping", is a primary cause of breathlessness, which often restricts a person’s ability to perform daily activities such as walking up stairs or taking a shower.3,4

Although COPD is the fourth leading cause of death worldwide, claiming 2.75 million lives annually,5 it is estimated that up to 75% of patients in Europe6 and 50% in the United States are undiagnosed.7 Results of the study presented today at the ERS congress showed that more than half of those affected with COPD may first be incorrectly diagnosed with asthma by their primary care physician.1



"The level of misdiagnosis and under diagnosis seen in this study is very concerning," said Professor David Price, Chair of Primary Care, Respiratory, University of Aberdeen, UK, and principal study investigator. "Although recent guidelines for COPD emphasise the importance of accurate diagnosis, this has been challenging in primary care. There has been varied evidence for COPD signs and symptoms, and insufficient tools to make an accurate diagnosis. As a result, patients are suffering unnecessarily because they’re not receiving appropriate treatment."

The study presented at ERS enrolled 597 patients recruited from primary care practices in the UK and US aged 40 years or older with prior diagnoses or medications consistent with obstructive lung disease, but not previously diagnosed with COPD.1 Patients were given a study diagnosis based on spirometry.

Approximately 40% of patients in the study were found to have COPD.1 Of these:

51.5% reported a prior diagnosis of asthma only1
10.6% reported no prior diagnosis of obstructive lung disease1
37.9% reported a prior diagnosis of COPD component diseases (chronic bronchitis or emphysema).1

Among those COPD sufferers originally misdiagnosed with asthma, or with no prior diagnosis of obstructive lung disease, only 3.5% were receiving anticholinergic treatments,1 which together with beta-agonists are central to the symptomatic management of COPD.8

"It’s time for primary care professionals to re-think their approach to COPD to ensure patients receive an early, correct diagnosis and appropriate, effective treatment. Early intervention with smoking cessation therapy may slow disease progression, and appropriate medical therapy may slow the deterioration in patient quality of life seen with COPD," Professor Price said.

Additional study results presented at ERS showed that diagnosis of COPD in ’at risk’ groups (smokers and ex-smokers over 40 years of age) could be vastly improved if patients were asked a few symptom-based diagnostic questions to assess their lung health.9 If these questions were used for screening purposes in a primary care practice setting, testing 1000 people at high risk would lead to 297 spirometric examinations and 110 new diagnoses of COPD.9

"This simple questionnaire promises to be a cost-effective means of improving diagnosis rates, and thus appropriate management of one of the most common, debilitating and costly conditions seen in primary care," Professor Price said.

Patrick Ward | EurekAlert!
Further information:
http://www.shirehealthinternational.com

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>